We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

42 hedge funds and large institutions have $700K invested in Oncolytics Biotech in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

2% more funds holding

Funds holding: 41 → 42 (+1)

0.35% more ownership

Funds ownership: 1.23% → 1.59% (+0.35%)

36% less capital invested

Capital invested by funds: $1.09M → $700K (-$389K)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ARC
Advisor Resource Council
Texas
+$122K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$86.5K
3
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$43K
4
Morgan Stanley
Morgan Stanley
New York
+$39.6K
5
TSS
Two Sigma Securities
New York
+$24.9K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$18K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$16.1K
3
Renaissance Technologies
Renaissance Technologies
New York
-$14K
4
Fifth Third Bancorp
Fifth Third Bancorp
Ohio
-$12.2K
5
CIBC World Market
CIBC World Market
Ontario, Canada
-$9.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.76K +$608 +500 +15%
National Bank of Canada
27
National Bank of Canada
Quebec, Canada
$3K – – –
SAM
28
Strategic Asset Management
Minnesota
$3K – – –
Bank of America
29
Bank of America
North Carolina
$3K +$232 +191 +6%
Fifth Third Bancorp
30
Fifth Third Bancorp
Ohio
$1K -$12.2K -10,000 -91%
ACM
31
Aquatic Capital Management
Illinois
$1K -$851 -700 -54%
IA
32
IFP Advisors
Florida
$1K – – –
SN
33
Sittner & Nelson
Oregon
$1K – – –
FBC
34
Fairfield, Bush & Co
Connecticut
$1K +$857 +705 New
TWC
35
TD Waterhouse Canada
Ontario, Canada
$511 – – –
IAIM
36
International Assets Investment Management
Florida
$182 – – –
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$34 -$3.65K -3,000 -8%
NDSI
38
Newman Dignan & Sheerar Inc
Rhode Island
– -$20 -12,915 Closed
Citadel Advisors
39
Citadel Advisors
Florida
– -$18K -11,639 Closed
ZB
40
Zions Bancorporation
Utah
– -$8K -5,000 Closed
MCC
41
Money Concepts Capital
Florida
– -$2K -1,060 Closed
HNWAG
42
High Net Worth Advisory Group
Florida
– -$1K -500 Closed
1
2

ONCY Hedge Fund Activity: Q2 2022 in Review

42 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q2 2022, worth a combined $700K — down 36% from $1.09M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ONCY positions and 6 closed out — a net gain of 1 holder — while 5 added to existing stakes and 9 trimmed.

The largest buyer was Advisor Resource Council, opening a new position worth an estimated $122K. The largest seller was Citadel Advisors, exiting entirely with an estimated $18K sold.

  • 42 institutional investors held Oncolytics Biotech (ONCY) as of Q2 2022, up from 41 in Q1 2022.
  • Funds reported $700K of Oncolytics Biotech stock for Q2 2022, down 36% quarter-over-quarter.
  • 7 funds opened new Oncolytics Biotech positions in Q2 2022 and 6 closed out, a net change of +1 holder.
  • The largest Oncolytics Biotech buyer in Q2 2022 was Advisor Resource Council, an estimated $122K added.
  • The largest Oncolytics Biotech seller in Q2 2022 was Citadel Advisors, an estimated $18K sold.

Based on aggregated 13F filings for Q2 2022.